151386-29-7

Basic information

• Product Name: 1-N-(2-cyclopentylethyl)-2,4-dioxo-5-N-(2-fluorophenyl)-3-phenylhydrazono-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine
• CAS NO: 151386-29-7
• Molecular Weight: 470.546
• Mol File: 151386-29-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-N-(2-cyclopentylethyl)-2,4-dioxo-5-N-(2-fluorophenyl)-3-phenylhydrazono-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-N-(2-cyclopentylethyl)-2,4-dioxo-5-N-(2-fluorophenyl)-3-phenylhydrazono-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine(151386-29-7)
• EPA Substance Registry System: 1-N-(2-cyclopentylethyl)-2,4-dioxo-5-N-(2-fluorophenyl)-3-phenylhydrazono-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine(151386-29-7)

Safety Data

• Hazardous Substances Data: 151386-29-7(Hazardous Substances Data)

Upstream product

• 5623-81-4 2-cyclopentylacetaldehyde 
• 28898-03-5 N-(2-fluorophenyl)benzene-1,2-diamine 
• 19288-90-5 2-(phenylhydrazono)-propanedioyl dichloride 
• 151386-28-6 2-(2-cyclopentylethyl)amino-2'-fluorodiphenylamine 

Downstream Products

• 153930-53-1 1-(2-cyclopentylethyl)-2,4-dioxo-5-(2-fluorophenyl)-3-isocyanato-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 
• 151620-69-8 3-amino-1-N-(2-cyclopentylethyl)-2,4-dioxo-5-N-(2-fluorophenyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 

Relevant articles and documents

Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazephines as cholecystokinin-B receptor antagonists

A series of 5-phenyl-3-ureidobenzodiazepine-2,4-diones was synthesized and evaluated as cholecystokinin-B (CCK-B) receptor antagonists. Structure-activity relationship (SAR) studies revealed the importance of the N-1 substituent for potent and selective C